Who Owns Turn Therapeutics Stock?
NASDAQ: TTRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 3.82%
- Held by insiders
- 53.88%
- Institutional holders
- 31
- Institutions 3.8%
- Insiders 53.9%
- Public and other 42.3%
Who owns Turn Therapeutics stock?
Institutional investors own about 3.8% of Turn Therapeutics's shares, spread across 31 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 53.88% of TTRX.
The largest institutional holders are SteelPeak Wealth, LLC (0.84%), IEQ Capital, LLC (0.76%) and Ddfg, Inc (0.36%). Together, the top 10 institutions control 3.1% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their TTRX positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of TTRX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| SteelPeak Wealth, LLC | 249.46K | 0.84% | +100.0% |
| IEQ Capital, LLC | 227.40K | 0.76% | +100.0% |
| Ddfg, Inc | 107.83K | 0.36% | +52.9% |
| Vanguard Capital Management LLC | 74.30K | 0.25% | +50.3% |
| Wellington Shields & Co., LLC | 65.73K | 0.22% | 0.0% |
| Millennium Management Llc | 60.55K | 0.20% | -13.2% |
| Blackrock Inc. | 38.59K | 0.13% | +100.0% |
| Aaron Wealth Advisors LLC | 32.56K | 0.11% | +100.0% |
| Tamar Securities, LLC | 30.00K | 0.10% | 0.0% |
| Royal Bank of Canada | 28.25K | 0.09% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of TTRX
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 62.75K | 0.21% |
| iShares Trust-iShares Micro-Cap ETF | 37.41K | 0.13% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 18.59K | 0.06% |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | 9.90K | 0.03% |
| EQ Advisors Trust-1290 VT Micro Cap Portfolio | 2.36K | 0.01% |
| Victory Portfolios III-Victory Extended Market Index Fund | 1.24K | 0.00% |
| VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd. | 129 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Turn Therapeutics?
SteelPeak Wealth, LLC is the largest institutional shareholder of TTRX, owning 0.84% of shares outstanding (249.46K shares) as of its latest 13F filing.
What percentage of Turn Therapeutics is owned by institutions?
Institutions own about 3.8% of TTRX shares and 8.3% of the public float.
How much of Turn Therapeutics do insiders own?
Insiders, such as officers and directors, own about 53.88% of TTRX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.